Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma
Clinical trial NCT00450307 · COMPLETED
Trial details
- NCT number
- NCT00450307
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2013-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.